CATX - Perspective Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.12 -0.04 (-2.12%) 0.0 (0.0%) 0.0 (-0.24%) -0.01 (-0.72%) --- -0.04 (-2.12%) 0.02 (0.94%) 0.02 (0.94%)

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.25
Diluted EPS:
-0.25
Basic P/E:
-8.3
Diluted P/E:
-8.3
RSI(14) 1m:
53.12
VWAP:
2.07
RVol:

Events

Period Kind Movement Occurred At

Related News